Nitrofurantoin: Difference between revisions
| Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{MM}} | {{CMG}}; {{AE}} {{MM}} | ||
==Overview== | ==Overview== | ||
'''Nitrofurantoin''' is an [[antibiotic]] which is marketed under the following brand names; '''Niftas''', '''Furadantin''', '''Furabid''', '''Macrobid''', '''Macrodantin''', '''Nitrofur Mac''', '''Nitro Macro''', '''Nifty-SR''', '''Martifur-MR''', '''Uro-Tablinen''' or '''Nifuretten''' (in Germany), '''Martifur-100''' (in India), '''Urantoin''', '''Nifuran''' (in Macedonia) and '''Uvamin''' (in Middle East). It is usually used in treating [[urinary tract infection]]. It is often used against ''[[Escherichia coli|E. coli]]''. | |||
==Category== | ==Category== | ||
Revision as of 17:17, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Nitrofurantoin is an antibiotic which is marketed under the following brand names; Niftas, Furadantin, Furabid, Macrobid, Macrodantin, Nitrofur Mac, Nitro Macro, Nifty-SR, Martifur-MR, Uro-Tablinen or Nifuretten (in Germany), Martifur-100 (in India), Urantoin, Nifuran (in Macedonia) and Uvamin (in Middle East). It is usually used in treating urinary tract infection. It is often used against E. coli.
Category
Urinary anti-infective
US Brand Names
MACROBID®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
The mechanism of the antimicrobial action of nitrofurantoin is unusual among antibacterials. Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates which inactivate or alter bacterial ribosomal proteins and other macromolecules. As a result of such inactivations, the vital biochemical processes of protein synthesis, aerobic energy metabolism, DNA synthesis, RNA synthesis, and cell wall synthesis are inhibited. Nitrofurantoin is bactericidal in urine at therapeutic doses. The broad-based nature of this mode of action may explain the lack of acquired bacterial resistance to nitrofurantoin, as the necessary multiple and simultaneous mutations of the target macromolecules would likely be lethal to the bacteria.[1]
References
- ↑ "FURADANTIN (NITROFURANTOIN) SUSPENSION [SHIONOGI INC.]". Text " accessdate " ignored (help)